<PAGE>
|--------------------------|
| OMB APPROVAL |
| ------------ |
| OMB Number 3235-0058 |
| Expires June 30, 1991 |
| Average estimated burden |
| hours per response 2.50|
----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
|---------------------------|
| SEC FILE NUMBER |
| 0-15457 |
-----------------------------
NOTIFICATION OF LATE FILING
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
|--------------------------|
| CUSIP NUMBER |
| 12556D-10-4 |
----------------------------
For Period Ended: December 31, 1994
-----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transaction Period Ended:_______________________________________
|------------------------------------------------------------------------------|
| Nothing in this form shall be construed to imply that the Commission has |
| verified any information contained herein. |
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
C.I.S. Technologies, Inc.
--------------------------------------------------------------------------------
Full Name of Registrant
--------------------------------------------------------------------------------
Former Name if Applicable
6100 South Yale Avenue, Suite 1900
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Tulsa, Oklahoma 74136
--------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
| (b) The subject annual report, semi-annual report, transition report
| on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,
[X]| will be filed on or before the fifteenth calendar day following
| the prescribed due date; or the subject quarterly report of
| transition report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, N-
SAR, or the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed)
Due to the occurrence of three significant transactions in the fourth quarter of
1994, and the resulting added disclosures required to be included in the Form
10-K, Registrant is unable to complete the document by March 31, 1995.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Richard A. Evans (918) 496-2451
----------------------- ----------- ---------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under [X] Yes [ ] No
Section 13 or 15(d) of the Securities Exchange Act of
1934 or Section 30 of the Investment Company Act of 1940
during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports)
been filed? If answer is no, identify report(s).
(3) Is it anticipated that any significant change in results [X] Yes [ ] No
of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
See attached Exhibit 99.
-------------------------------------------------------------------------------
C.I.S. Technologies, Inc.
----------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: March 31, 1995 By: /s/ Richard A. Evans
-------------- --------------------
Richard A. Evans
Chief Financial Officer and Treasurer
<PAGE>
NEWS RELEASE
CIS TECHNOLOGIES, INC.
6100 SOUTH YALE
SUITE 1900
TULSA, OK 74136-1903
FOR IMMEDIATE RELEASE CONTACT: RICHARD A. EVANS
CHIEF FINANCIAL OFFICER
(918) 496-2451
CIS TECHNOLOGIES, INC. ANNOUNCES FINANCIAL RESULTS
TULSA, Oklahoma (February 8, 1995) - CIS Technologies, Inc. (Nasdaq/NM:CISI)
today announced its financial results for the fourth quarter and year ended
December 31, 1994.
Philip D. Kurtz, chairman and chief executive officer of CIS Technologies,
said "During calendar year 1994, our Company's financial performance improved,
and we successfully repositioned ourselves to meet the challenges and realize
the opportunities created by a healthcare industry undergoing revolutionary
change. Despite the absence of legislation, unprecedented, market-driven
healthcare reform is sweeping the nation and creating exciting opportunities for
the Company. During 1994, we initiated major new business strategies, created
strategic alliances and developed a platform for strong earnings growth. In
1995, we expect to capitalize on the strong foundation created in 1994 to
produce consistent revenue and earnings growth."
For the quarter ended December 31, 1994, revenue was $8.9 million compared to
$7.8 million for the fourth quarter of 1993. Fourth quarter 1994 net income was
$660,000, or $0.02 per share, compared to net income of $726,000, or $0.03 per
share, for the same quarter in 1993. The decrease was due primarily to
increased operating costs associated with new product releases.
Revenue for the year ended December 31, 1994, was $31.7 million compared to
$33.3 million for the same period last year. Net income for 1994 was $2.2
million, or $0.08 per share, compared to $1.2 million, or $0.05 per share, for
the prior year.
James L. Hersma, president and chief operating officer of CIS Technologies,
said, "We are pleased with these financial results, but far from satisfied.
Even though we exceeded our objectives for earnings per share, we consider 1994
just the first step to substantially improved financial and operating results.
The important initiatives introduced in 1994 position the Company for strong
performance in 1995 and beyond as we move forward to achieve added value for our
shareholders."
-MORE
<PAGE>
In the fourth quarter, the Company announced three major developments which
are expected to have a long-term impact on profitability. Near the end of 1994,
the Company completed the acquisition of Orlando, Florida-based Automated
Medical Systems Consultants, Inc., the nation's leading reseller of the Medical
Manager(R) physician practice management software, which allows the Company to
assume a prominent role in the physician information management marketplace.
The Company also announced that it had entered into two strategic alliances.
The first, with GE Capital, positions CIS Technologies to provide accounts
receivable financing to the healthcare industry, while the second, with Bankers
Trust, enables the Company to pursue opportunities in cash management and data
services in the healthcare industry. Both GE Capital and Bankers Trust made
significant equity and/or debt investments in CIS. "We take great pride in the
fact that two highly respected financial institutions have invested in CIS and
our future," Hersma said.
CIS Technologies, Inc. is a leading provider of automated products and
services that help hospitals to process claims, manage data electronically, and
increase hospital cash flow through a wide range of professional services. CIS'
products and services are used by over 700 healthcare providers in 38 states,
and CIS processes and manages over $50 billion in healthcare claims annually.
CIS TECHNOLOGIES, INC.
UNAUDITED FINANCIAL HIGHLIGHTS
(In thousands, except per share amounts)
<TABLE>
<CAPTION>
THREE MONTHS ENDED
DECEMBER 31,
-----------------
1994 1993
------- --------
<S> <C> <C>
Revenue $ 8,931 $ 7,832
Operating income $ 630 $ 707
Net income $ 660 $ 726
Net income per share $ 0.02 $ 0.03
YEAR ENDED
DECEMBER 31,
-----------------
1994 1993
------- -------
Revenue $31,689 $33,285
Operating income (loss) $ 2,337 $ (226)
Income before cumulative effect of accounting change $ 2,197 $ 321
Net income $ 2,197 $ 1,221
Income per share:
Before cumulative effect of accounting change $ .08 $ 0.02
Net income per share $ .08 $ 0.05
</TABLE>
###
